Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Deprescribing or represcribing? Good drugs, bad drugs in older adults].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Prescribing cascades: do we need this construct?

European geriatric medicine·2025
Same author

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

European geriatric medicine·2021
Same author

[Polyneuropathies-many causes, complicated treatment].

Der Internist·2020
Same author

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

Drugs & aging·2019
Same author

[Cardiovascular pharmacotherapy in the elderly : To avoid overtreatment and undertherapy].

Herz·2018

Related Experiment Videos

[Paracetamol. Efficacious and safe for all ages].

M Wehling1

  • 1Klinische Pharmakologie Mannheim, Zentrum für Gerontopharmakologie, Medizinische Fakultät Mannheim, Universität Heidelberg, Maybachstr. 14, 68169, Mannheim, Deutschland. martin.wehling@medma.uni-heidelberg.de

Schmerz (Berlin, Germany)
|December 11, 2012
PubMed
Summary

Paracetamol is a safe and effective pain reliever when used cautiously, despite concerns about liver toxicity. Alternative analgesics pose greater risks, making paracetamol a viable option, especially for the elderly with dose limits.

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Geriatrics
  • Toxicology

Background:

  • Paracetamol's safety is under scrutiny in Germany due to hepatic toxicity concerns.
  • Debate exists regarding market withdrawal or prescription status for paracetamol.
  • Alternative analgesics present significant risks, including gastrointestinal bleeding and cardiovascular side effects.

Purpose of the Study:

  • To analyze the safety record of paracetamol.
  • To evaluate the suitability of paracetamol for treating elderly patients.
  • To provide an objective assessment of paracetamol's risk-benefit profile.

Main Methods:

  • Extensive review of paracetamol's safety data.
  • Comparative analysis of fatal analgesic poisoning cases in Germany.
  • Application of safety findings to geriatric patient populations.

Main Results:

  • In 2010, paracetamol accounted for only 4 fatal poisonings in Germany, compared to 16 for diclofenac and ibuprofen.
  • Paracetamol is effective and safe when used with appropriate precautions.
  • Elderly patients, including the very elderly, can be safely treated with paracetamol, with a recommended dose limit of 3 g/day.

Conclusions:

  • Paracetamol remains a safer alternative to other analgesics, particularly concerning gastrointestinal and cardiovascular risks.
  • Concerns regarding paracetamol's safety in Germany are not supported by comparative data and should not be generalized from other regions.
  • Objective reasoning should guide the discussion on paracetamol's use, especially in the elderly population with dose adjustments.